Introduction: Cardiovascular diseases are the most frequent cause of mortality in
hemodialysis patients. Increased total plasma homocysteine is a risk factor for development …

Aim The aim of the study was to determine the prevalence of hyperhomocysteinemia and its
relationship with other cardiovascular risk factors in dialysis patients. Methods Blood …

Cardiovascular diseases connected with atherosclerosis are the main factor of morbidity and
mortality in patients with end-stage renal failure. Hyperhomocysteinemia is a known and …

The risk of premature and progressive occlusive vascular disease is high in chronic uremic
patients, and it accounts for more than 40% of the mortality in dialysis patients. End stage …

The end-stage renal disease (ESRD) population experiences an excess morbidity and
mortality due to arteriosclerotic cardiovascular disease (CVD) outcomes. Specifically, event …

Introduction Hyperhomocysteinemia is an independent risk factor for premature
cardiovascular disease. In this study we examined the prevalence of high plasma levels of …

AIM: To determine the effect of plasma homocysteine (Hc) on the structure and function of
the left ventricle (LV) in patients treated by programmed hemodialysis/MATERIAL AND …

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
Background We prospectively tested the prediction power of homocysteinemia for all-cause …

Aim: Cardiovascular diseases are leading cause of death in patients with chronic renal
failure. The aim of our study was to establish connection between levels of homocysteine …

Results. It was established that in patients with chronic renal failure, a normal level of НHC is
found in 26 (21.1%), subnormal in 34 (27.7%), mild HC in 30 (24.4%), average HНC in 33 …